Message to Clinicians – Nirmatrelvir/Ritonavir (Paxlovid)

A special message on nirmatrelvir/ritonavir (Paxlovid) to clinicians from CDC Director Rochelle P. Walensky, MD, MPH

This video can also be viewed at

Recommend0 recommendationsPublished in US National Health Agency Sources

Related Articles

The COVID-19 Booster Shot and What Latinos Should Know

As medical experts work to fight back the COVID-19 Delta variant, the CDC released new vaccine guidelines that a third booster shot will be necessary. The CDC recommends that a booster shot be implemented eight months after the second dose of the COVID-19 vaccine to provide “long lasting protection.” The booster shot is expected to …
The post The COVID-19 Booster Shot and What Latinos Should Know appeared first on Salud America.

Meet the 2021 Exito! Latino Cancer Research Trainees

Program leaders have selected 26 aspiring Latino researchers from across the nation to join the 2021 cohort of Éxito! Latino Cancer Research Leadership Training at UT Health San Antonio. Each year, Éxito! recruits U.S. master’s level students and professionals to participate in a five-day, culturally tailored Éxito! summer institute to promote pursuit of a doctoral degree and cancer research. The …
The post Meet the 2021 Exito! Latino Cancer Research Trainees appeared first on Salud America.

Responses